Lv1
60 积分 2025-10-19 加入
TROPION-Lung02: Datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy for advanced non-small cell lung cancer (aNSCLC)
14天前
已完结
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
24天前
已完结